Ovoca Bio | OVG - Net Income


Ovoca Bio reported EUR-5.65M in Net Income for its fiscal semester ending in June of 2022.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
ALKERMES USD 49.34M 33.42M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Great Western Mining Corporation EUR -527.99K 184.38K Jun/2023
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025